THERION BIOLOGICS

Mark For: THERION BIOLOGICS® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of HIV, cancers, including leukemia, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma and metastic cancers; vaccines and recombinant vectors of pox and component immune-stimulatory agents used in said vaccines to produce biological immunogens for use in humans. [all]

Status

2022-07-20 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	76420341
Registration Number	2763725
Mark Literal Elements	THERION BIOLOGICS
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	SCANNING ON DEMAND 2007-06-29
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	CHRISTINE M. BAKER
Attorney Docket Number	09999-523
Law Office Assigned	M60
Employee Name	SOUDERS, MICHAEL J

Timeline

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for the treatment of HIV, cancers, including leukemia, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma and metastic cancers; vaccines and recombinant vectors of pox and component immune-stimulatory agents used in said vaccines to produce biological immunogens for use in humans. FIRST USE: 19930819. FIRST USE IN COMMERCE: 19930819(CANCELLED)
IC 042. US 100 101. G & S: pharmaceutical research and development. FIRST USE: 19930819. FIRST USE IN COMMERCE: 19930819